1. Academic Validation
  2. G-quadruplexes in an SVA retrotransposon cause aberrant TAF1 gene expression in X-linked dystonia parkinsonism

G-quadruplexes in an SVA retrotransposon cause aberrant TAF1 gene expression in X-linked dystonia parkinsonism

  • Nucleic Acids Res. 2024 Oct 28;52(19):11571-11586. doi: 10.1093/nar/gkae797.
Giulia Nicoletto 1 Marianna Terreri 1 Ilaria Maurizio 1 Emanuela Ruggiero 1 Filippo M Cernilogar 2 3 Christine A Vaine 4 Maria Vittoria Cottini 1 Irina Shcherbakova 3 Ellen B Penney 4 Irene Gallina 1 David Monchaud 5 D Cristopher Bragg 4 Gunnar Schotta 3 Sara N Richter 1 6
Affiliations

Affiliations

  • 1 Department of Molecular Medicine, University of Padua, via A. Gabelli 63, 35121 Padua, Italy.
  • 2 Department of Science and Technological Innovation, University of Piemonte Orientale, Viale Teresa Michel 11, 15121, Alessandria, Italy.
  • 3 Molecular Biology Division, Biomedical Center, Ludwig Maximilian University of Munich, Großhaderner Strasse 9, 82152 Planegg-Martinsried, Germany.
  • 4 Department of Neurology, Massachusetts General Hospital, Building 149 13th Street, Charlestown, MA 02129, USA.
  • 5 Institut de Chimie Moleculaire de l'Université de Bourgogne, ICMUB CNRS UMR6302, 9, Rue Alain Savary, 21078 Dijon, France.
  • 6 Microbiology and Virology Unit, Padua University Hospital, via Giustiniani 2, 35121 Padua, Italy.
Abstract

G-quadruplexes (G4s) are non-canonical nucleic acid structures that form in guanine (G)-rich genomic regions. X-linked dystonia parkinsonism (XDP) is an inherited neurodegenerative disease in which a SINE-VNTR-Alu (SVA) retrotransposon, characterised by amplification of a G-rich repeat, is inserted into the coding sequence of TAF1, a key partner of RNA polymerase II. XDP SVA alters TAF1 expression, but the cause of this outcome in XDP remains unknown. To assess whether G4s form in XDP SVA and affect TAF1 expression, we first characterised bioinformatically predicted XDP SVA G4s in vitro. We next showed that highly stable G4s can form and stop polymerase amplification at the SVA region from patient-derived fibroblasts and neural progenitor cells. Using chromatin immunoprecipitazion (ChIP) with an anti-G4 antibody coupled to Sequencing or quantitative PCR, we showed that XDP SVA G4s are folded even when embedded in a chromatin context in patient-derived cells. Using the G4 ligands BRACO-19 and quarfloxin and total RNA-sequencing analysis, we showed that stabilisation of the XDP SVA G4s reduces TAF1 transcripts downstream and around the SVA, and increases upstream transcripts, while destabilisation using the G4 unfolder PhpC increases TAF1 transcripts. Our data indicate that G4 formation in the XDP SVA is a major cause of aberrant TAF1 expression, opening the way for the development of strategies to unfold G4s and potentially target the disease.

Figures
Products